|Forum - Pinks and BB
||Pinks And BB Top Stock Picks|
|From: firechief701 (Rep: 3)||Date: 10/01/2018 12:02|
|Forum: Pinks and BB - Msg #130611||Thread #674038236 (Rec: 0) |
|About Liberty Health Sciences|
First of all, Liberty Health Sciences has a couple of things in common with Tilray. Both companies are based in Canada; Liberty's headquarters are in Toronto. Both Liberty and Tilray also grow marijuana for medical use.
While Liberty Health Sciences is a Canadian company, its core operations are in Florida. The company recently began production at its Gainesville, Florida, cannabis facility. This new facility combined with Liberty's existing Chestnut Hill facility gives the company 41,200 square feet of growing space.
The company's capacity will increase significantly very soon, though. Liberty has another retrofitting project underway that should boost its total growing space to around 225,000 square feet by early next year. When completed, Liberty Health Sciences will rank as the No. 1 medical marijuana producer in Florida in terms of production capacity.
Liberty already operates four dispensaries in Florida along with six delivery hubs. The company anticipates opening seven additional dispensaries throughout the state by February 2019. The state of Florida allows licensed producers to operate up to 30 dispensaries.
But Liberty doesn't make its customers come to it; the company also takes its products to its customers. Liberty offers home delivery within 24 hours to medical cannabis patients throughout the state of Florida.
The company has had a close relationship with Aphria (NASDAQOTH: APHQF). In fact, Aphria owned a big stake in Liberty Health Sciences until it ran into trouble with the Toronto Stock Exchange. The TSX doesn't allow marijuana growers with stocks listed on its exchange to maintain significant operations in the U.S., where marijuana remains illegal at the federal level.
Aphria ended up divesting its ownership in Liberty. However, Aphria has a lock-up agreement in place that allows it to buy its shares of Liberty back within an 18-month period beginning in July 2018 if U.S. federal laws change. In the meantime, Aphria CEO Vic Neufeld continues to serve as chairman of Liberty Health Sciences' board of directors. Another Aphria executive, John Cervini, also is a member of Liberty's board.
TheLion.com | About Us | Agreement & Disclaimer | Privacy | Twitter
© 1999- TheLion.com, Inc.